Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DB26FATZK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,429
Award facts
- Contract value 100% obligated
- $4,429.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,429.39 to DMS Pharmaceutical Group Inc. for 8-tablet units of NURTEC ODT 75 mg tablets, with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order was issued without set-aside designation to the woman-owned small business pharmaceutical wholesaler, which is headquartered in Park Ridge, Illinois and specializes in distributing pharmaceutical products and medical consumables to federal agencies. The place of performance is identified as Conshohocken, Pennsylvania.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical supplies to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR, was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036, establishing DMS Pharmaceutical Group as a critical pharmaceutical supplier supporting Department of Defense medical operations globally. The contract structure authorizes the agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to meet the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FATZK?
SPE2DB26FATZK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZK worth?
The government has obligated $4,429 on SPE2DB26FATZK.
Is contract SPE2DB26FATZK an order under another contract?
Yes. SPE2DB26FATZK is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZK competed?
The extent of competition for SPE2DB26FATZK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award